Geisinger Health has teamed up with Swiss-based device-maker Medacta International in a pilot program guaranteeing lifetime coverage of hip replacement costs for Geisenger patients.
A pilot hip-replacement program initiated in late February by device-maker Medacta International and health system Geisinger Health will cover all the costs of initial hip replacement surgery, revisions and hip replacements in later years – as long as the patient stays on the Geisinger health plan.
Under its "ProvenCare Total Hip" program, Geisinger says it will "stand behind the costs of a hip surgery for a lifetime." The health system has experience in orthopedic bundled care...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
